Search Grant Opportunities

Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)

ID: RFA-MH-25-186 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.
Background
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes the advancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness.

Grant Details
The NOFO uses the R21 grant mechanism. The research objectives include advancing pharmacy-based health screenings for HIV alongside screenings for multiple chronic illnesses and common comorbid conditions, creating and scaling models of pharmacy-based HIV PrEP delivery and adherence support, improving access and use of HIV post-exposure prophylaxis (PEP) through pharmacies, expanding the delivery and use of long-acting injectable PrEP and/or ART regimens though pharmacists and pharmacies.
Testing pharmacy-based monitoring and support for antiretroviral treatment adherence is also a key objective. Additionally, the NOFO aims to advance prescription refill synchronization for HIV and other chronic conditions to improve medication adherence and health outcomes. It also seeks to advance integrated services for HIV and other common comorbid conditions or chronic illnesses through pharmacies and pharmacists. Furthermore, it aims to use pharmacists and pharmacies as a vector for engaging youth, pregnant persons, or minoritized populations in HIV testing, prevention, or care.

Eligibility Requirements
Eligible applicants include higher education institutions, nonprofits with 501(c)(3) IRS status (other than institutions of higher education), for-profit organizations (including small businesses), local governments, state governments, federal governments, U.S. territories or possessions, independent school districts, public housing authorities/Indian housing authorities, Native American tribal organizations (other than federally recognized tribal governments), faith-based or community-based organizations, regional organizations. Foreign organizations are also eligible to apply.

Period of Performance
The maximum project period is 2 years.

Grant Value
NIMH along with the participating ICs intend to commit a total of $11,250,000 in FY 2025 to fund 8-12 awards in response to this NOFO. The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Place of Performance
Research can occur at performance sites including relevant U.S. and foreign institutions.

Overview

On 4/29/24 the National Institutes of Health posted grant opportunity RFA-MH-25-186 for Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional). The grant will be issued under grant program 93.242 Mental Health Research Grants.

Timing

Posted Date
April 29, 2024, 12:00 a.m. EDT
Closing Date
Aug. 13, 2024, 12:00 a.m. EDT Past Due
Last Updated
April 29, 2024, 10:49 a.m. EDT
Version
1
Archive Date
Sept. 18, 2024

Eligibility

Eligible Applicants
Small businesses
Independent school districts
Public and State controlled institutions of higher education
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
County governments
Public housing authorities/Indian housing authorities
Others (see text field entitled "Additional Information on Eligibility" for clarification)
For profit organizations other than small businesses
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-186.html

Documents

Posted documents for RFA-MH-25-186

Grant Awards

Grants awarded through RFA-MH-25-186

Incumbent or Similar Grants

Grants similar to RFA-MH-25-186

Similar Active Opportunities

Open grant opportunities similar to RFA-MH-25-186

Experts for Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)

Recommended subject matter experts available for hire